Insider

Andrew J Murphy

Co-Chief Scientific Officer · Regeneron Pharmaceuticals, Inc. (REGN)

sold: $3,204,376 · planned sales: $4,773,278

DateTradeSharesAvg. priceValueFiling
November 17, 2026Planned sale 10b5-1 plan5,011—$4,773,278SEC
October 14, 2026Sale 10b5-1 plan notice filed4,147$772.70$3,204,376SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.